Rahul Naidoo, Superscript, on Rewriting the Rules of Healthcare Pricing
Wed Feb 04 2026
In this episode of The Pulse, I sat down with Rahul Naidoo, co-founder and CEO of Superscript, an early-stage health tech company on a mission to redefine the financial experience in healthcare for both patients and providers.
Founded in 2021, Superscript spent nearly three years in R&D building what Rahul calls “healthcare’s first pricing protocol” — technology that turns surprise, after-the-fact medical bills into clear, upfront prices. The company now works with nearly 300 providers across New York, New Jersey, and Texas, has empowered close to 50,000 patients with upfront prices, and is backed by investors including Mark Cuban, early backers of Uber and SpaceX, and founders from Dropbox and Everly Health.
Rahul and I talked about his unconventional journey from Cape Town to Harvard to health tech founder, why he believes consumer-style pricing is the missing backbone of U.S. healthcare, and how Superscript is betting on a radically different approach to pricing transparency — one that doesn’t just “estimate” costs, but actually takes on financial risk to guarantee them.
More
In this episode of The Pulse, I sat down with Rahul Naidoo, co-founder and CEO of Superscript, an early-stage health tech company on a mission to redefine the financial experience in healthcare for both patients and providers. Founded in 2021, Superscript spent nearly three years in R&D building what Rahul calls “healthcare’s first pricing protocol” — technology that turns surprise, after-the-fact medical bills into clear, upfront prices. The company now works with nearly 300 providers across New York, New Jersey, and Texas, has empowered close to 50,000 patients with upfront prices, and is backed by investors including Mark Cuban, early backers of Uber and SpaceX, and founders from Dropbox and Everly Health. Rahul and I talked about his unconventional journey from Cape Town to Harvard to health tech founder, why he believes consumer-style pricing is the missing backbone of U.S. healthcare, and how Superscript is betting on a radically different approach to pricing transparency — one that doesn’t just “estimate” costs, but actually takes on financial risk to guarantee them.